Time-restricted eating has been found to improve cardiometabolic health, insulin resistance, glycemic management, and blood pressure independent of weight loss. It can even affect polycystic ovary syndrome (PCOS), explained Sofia Cienfuegos, PhD, MS.
Developed by leading investigators in the field in a closed-door expert forum earlier in the week, the program will take a bench-to-bedside perspective, reviewing what is currently known and identify knowledge gaps with the aim of spurring future research and translation of emerging concepts.
The ADA’s Outstanding Educator in Diabetes for 2024, Joshua J. Neumiller, PharmD, CDCES, FADCES, FASCP, had his understanding of the disease reframed when he was diagnosed with type 1 diabetes as a graduate student.
Patti Urbanski, MEd, RD, LD, CDCES, FADCES, highlighted research on the effectiveness of diabetes education, weaving in her personal experience as a person with type 1 diabetes and as a diabetes educator.
Semaglutide is best known as a weight loss drug, yet SELECT was not a weight loss study. It was a secondary cardioprevention trial, explained Donna H. Ryan, MD, one of the experts presenting results from SELECT.
The drug has been shown to improve sleep apnea severity and related cardiometabolic issues in people with moderate-to-severe obstructive sleep apnea, reported investigators including Atul Malhotra, MD, and Louis J. Aronne, MD, FACP, DABOM.
Study Chair Irl B. Hirsch, MD, reported that inhaled insulin may be good for patients who are engaged in their diabetes self-management and want to reduce hyperglycemia even further, and for patients who want an alternative to a pump.
“The role of the central nervous system (CNS) in metabolic regulation has important implications for normal physiology and for disease, and this symposium was constructed to highlight how these may contribute to diabetes,” said Diabetes® Editor in Chief David A. D’Alessio, MD.
Gamification, prescriptions for fresh produce, and nutrition education have proven successful components to diabetes prevention and treatment. Panelists including Grace E. Shearrer, PhD, will explain how these concepts have been put into action in the real world.
A Sunday symposium will explore evolving evidence for CGM use in pregnancy. Sarit Polsky, MD, MPH, one of the expert panelists, will compare time in range versus conventional fasting and postprandial targets in pregnancy.